Engineered Fibrillar Fibronectin Networks as Three‐Dimensional Tissue Scaffolds
Extracellular matrix (ECM) proteins, and most prominently, fibronectin (Fn), are routinely used in the form of adsorbed pre‐coatings in an attempt to create a cell‐supporting environment in both two‐ and three‐dimensional cell culture systems. However, these protein coatings are typically deposited in a form which is structurally and functionally distinct from the ECM‐constituting fibrillar protein networks naturally deposited by cells. Here, the cell‐free and scalable synthesis of freely suspended and mechanically robust three‐dimensional (3D) networks of fibrillar fibronectin (fFn) supported by tessellated polymer scaffolds is reported. Hydrodynamically induced Fn fibrillogenesis at the three‐phase contact line between air, an Fn solution, and a tessellated scaffold microstructure yields extended protein networks. Importantly, engineered fFn networks promote cell invasion and proliferation, enable in vitro expansion of primary cancer cells, and induce an epithelial‐to‐mesenchymal transition in cancer cells. Engineered fFn networks support the formation of multicellular cancer structures cells from plural effusions of cancer patients. With further work, engineered fFn networks can have a transformative impact on fundamental cell studies, precision medicine, pharmaceutical testing, and pre‐clinical diagnostics.
Top-30
Journals
|
1
2
3
|
|
|
Advanced Functional Materials
3 publications, 6.52%
|
|
|
Advanced healthcare materials
3 publications, 6.52%
|
|
|
Frontiers in Oncology
2 publications, 4.35%
|
|
|
Materials and Design
2 publications, 4.35%
|
|
|
Advanced NanoBiomed Research
2 publications, 4.35%
|
|
|
Nano Letters
2 publications, 4.35%
|
|
|
ACS applied materials & interfaces
1 publication, 2.17%
|
|
|
Journal of the Royal Society Interface
1 publication, 2.17%
|
|
|
Cancers
1 publication, 2.17%
|
|
|
Bioengineering
1 publication, 2.17%
|
|
|
Frontiers in Molecular Biosciences
1 publication, 2.17%
|
|
|
Bio-Design and Manufacturing
1 publication, 2.17%
|
|
|
Breast Cancer Research
1 publication, 2.17%
|
|
|
Materials Today Advances
1 publication, 2.17%
|
|
|
Acta Biomaterialia
1 publication, 2.17%
|
|
|
Advanced Drug Delivery Reviews
1 publication, 2.17%
|
|
|
Current Opinion in Cell Biology
1 publication, 2.17%
|
|
|
Small Structures
1 publication, 2.17%
|
|
|
Advanced Electronic Materials
1 publication, 2.17%
|
|
|
Journal of Materials Chemistry B
1 publication, 2.17%
|
|
|
Journal of Inorganic Materials
1 publication, 2.17%
|
|
|
Methods in Molecular Biology
1 publication, 2.17%
|
|
|
Annals of Clinical and Translational Neurology
1 publication, 2.17%
|
|
|
Advanced Science
1 publication, 2.17%
|
|
|
Bioactive Materials
1 publication, 2.17%
|
|
|
Emergent Materials
1 publication, 2.17%
|
|
|
Biomaterials
1 publication, 2.17%
|
|
|
Cells
1 publication, 2.17%
|
|
|
Nature Reviews Cancer
1 publication, 2.17%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
14
|
|
|
Wiley
13 publications, 28.26%
|
|
|
Elsevier
9 publications, 19.57%
|
|
|
Springer Nature
8 publications, 17.39%
|
|
|
American Chemical Society (ACS)
3 publications, 6.52%
|
|
|
MDPI
3 publications, 6.52%
|
|
|
Frontiers Media S.A.
3 publications, 6.52%
|
|
|
The Royal Society
1 publication, 2.17%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 2.17%
|
|
|
Shanghai Institute of Ceramics
1 publication, 2.17%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 2.17%
|
|
|
Annual Reviews
1 publication, 2.17%
|
|
|
Akademiai Kiado
1 publication, 2.17%
|
|
|
2
4
6
8
10
12
14
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.